NF	0	2	B-Gene_or_gene_product
-	2	3	I-Gene_or_gene_product
kappaB	3	9	I-Gene_or_gene_product
and	10	13	O
IKK	14	17	B-Gene_or_gene_product
as	18	20	O
therapeutic	21	32	O
targets	33	40	O
in	41	43	O
cancer	44	50	B-Pathological_formation
.	50	51	O

The	53	56	O
transcription	57	70	O
factor	71	77	O
NF	78	80	B-Gene_or_gene_product
-	80	81	I-Gene_or_gene_product
kappaB	81	87	I-Gene_or_gene_product
and	88	91	O
associated	92	102	O
regulatory	103	113	O
factors	114	121	O
(	122	123	O
including	123	132	O
IkappaB	133	140	B-Gene_or_gene_product
kinase	141	147	O
subunits	148	156	O
and	157	160	O
the	161	164	O
IkappaB	165	172	B-Gene_or_gene_product
family	173	179	O
member	180	186	O
Bcl	187	190	B-Gene_or_gene_product
-	190	191	I-Gene_or_gene_product
3	191	192	I-Gene_or_gene_product
)	192	193	O
are	194	197	O
strongly	198	206	O
implicated	207	217	O
in	218	220	O
a	221	222	O
variety	223	230	O
of	231	233	O
hematologic	234	245	O
and	246	249	O
solid	250	255	B-Pathological_formation
tumor	256	261	I-Pathological_formation
malignancies	262	274	O
.	274	275	O

A	276	277	O
role	278	282	O
for	283	286	O
NF	287	289	B-Gene_or_gene_product
-	289	290	I-Gene_or_gene_product
kappaB	290	296	I-Gene_or_gene_product
in	297	299	O
cancer	300	306	B-Cell
cells	307	312	I-Cell
appears	313	320	O
to	321	323	O
involve	324	331	O
regulation	332	342	O
of	343	345	O
cell	346	350	O
proliferation	351	364	O
,	364	365	O
control	366	373	O
of	374	376	O
apoptosis	377	386	O
,	386	387	O
promotion	388	397	O
of	398	400	O
angiogenesis	401	413	O
,	413	414	O
and	415	418	O
stimulation	419	430	O
of	431	433	O
invasion	434	442	O
/	442	443	O
metastasis	443	453	O
.	453	454	O

Consistent	455	465	O
with	466	470	O
a	471	472	O
role	473	477	O
for	478	481	O
NF	482	484	B-Gene_or_gene_product
-	484	485	I-Gene_or_gene_product
kappaB	485	491	I-Gene_or_gene_product
in	492	494	O
oncogenesis	495	506	O
are	507	510	O
observations	511	523	O
that	524	528	O
inhibition	529	539	O
of	540	542	O
NF	543	545	B-Gene_or_gene_product
-	545	546	I-Gene_or_gene_product
kappaB	546	552	I-Gene_or_gene_product
alone	553	558	O
or	559	561	O
in	562	564	O
combination	565	576	O
with	577	581	O
cancer	582	588	B-Pathological_formation
therapies	589	598	O
leads	599	604	O
to	605	607	O
tumor	608	613	B-Cell
cell	614	618	I-Cell
death	619	624	O
or	625	627	O
growth	628	634	O
inhibition	635	645	O
.	645	646	O

However	647	654	O
,	654	655	O
other	656	661	O
experimental	662	674	O
data	675	679	O
indicate	680	688	O
that	689	693	O
NF	694	696	B-Gene_or_gene_product
-	696	697	I-Gene_or_gene_product
kappaB	697	703	I-Gene_or_gene_product
can	704	707	O
play	708	712	O
a	713	714	O
tumor	715	720	B-Pathological_formation
suppressor	721	731	O
role	732	736	O
in	737	739	O
certain	740	747	O
settings	748	756	O
and	757	760	O
that	761	765	O
it	766	768	O
can	769	772	O
be	773	775	O
important	776	785	O
in	786	788	O
promoting	789	798	O
an	799	801	O
apoptotic	802	811	O
signal	812	818	O
downstream	819	829	O
of	830	832	O
certain	833	840	O
cancer	841	847	O
therapy	848	855	O
regimens	856	864	O
.	864	865	O

In	866	868	O
order	869	874	O
to	875	877	O
appropriately	878	891	O
move	892	896	O
NF	897	899	B-Gene_or_gene_product
-	899	900	I-Gene_or_gene_product
kappaB	900	906	I-Gene_or_gene_product
inhibitors	907	917	O
in	918	920	O
the	921	924	O
clinic	925	931	O
,	931	932	O
thorough	933	941	O
approaches	942	952	O
must	953	957	O
be	958	960	O
initiated	961	970	O
to	971	973	O
determine	974	983	O
the	984	987	O
molecular	988	997	O
mechanisms	998	1008	O
that	1009	1013	O
dictate	1014	1021	O
the	1022	1025	O
complexity	1026	1036	O
of	1037	1039	O
oncologic	1040	1049	O
and	1050	1053	O
therapeutic	1054	1065	O
outcomes	1066	1074	O
that	1075	1079	O
are	1080	1083	O
controlled	1084	1094	O
by	1095	1097	O
NF	1098	1100	B-Gene_or_gene_product
-	1100	1101	I-Gene_or_gene_product
kappaB	1101	1107	I-Gene_or_gene_product
.	1107	1108	O

